Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Boyd

Showing results (511-520 of 565) with videos related to

Pageof 57
Sort By:
Health Promotion Practice|November 22, 2023
Implementation of Overdose Prevention in Maryland: Implications for Resource Allocation, Program Scale-Up, and EvaluationCatherine Tomko, Saba Rouhani, Renee M Johnson, et al.
Diabetes|January 9, 2001
Glucagon-like peptide 1 stimulates lipolysis in clonal pancreatic beta-cells (HIT)G C Yaney, V N Civelek, A M Richard, et al.
Leukemia Research|August 17, 2018
CC-486 (oral azacitidine) in patients with myelodysplastic syndromes with pretreatment thrombocytopeniaGuillermo Garcia-Manero, Bart L Scott, Christopher R Cogle, et al.
Journal of Medicinal Chemistry|October 13, 1995
Piperazinylalkyl heterocycles as potential antipsychotic agentsM K Scott, E W Baxter, D J Bennett, et al.
Bioorganic & Medicinal Chemistry|September 6, 2002
Synthesis of (-)-5,8-dihydroxy-3R-methyl-2R-(dipropylamino)-1,2,3,4-tetrahydronaphthalene: an inhibitor of beta-amyloid(1-42) aggregationMichael H Parker, Robert Chen, Kelly A Conway, et al.
Pancreas|March 20, 2013
Improving the success rate of gluteal intramuscular injectionsApril E Boyd, Linda L DeFord, Jeannette E Mares, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 14, 2007
Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemiaSusan O'Brien, Joseph O Moore, Thomas E Boyd, et al.
Journal of Medicinal Chemistry|February 7, 2001
Alpha(2) adrenoceptor agonists as potential analgesic agents. 2. Discovery of 4-(4-imidazo)-1,3-dimethyl-6,7-dihydro-thianaphthene as a high-affinity ligand for the alpha(2D) adrenergic receptorT M Ross, M C Jetter, M E McDonnell, et al.
The Journal of Biological Chemistry|October 9, 2009
Characterization of a serine protease homologous to house dust mite group 3 allergens from the scabies mite Sarcoptes scabieiSimone A Beckham, Sarah E Boyd, Simone Reynolds, et al.
CJC Open|June 21, 2021
Cardiovascular and Renal Risk Factors and Complications Associated With COVID-19Rhian M Touyz, Marcus O E Boyd, Tomasz Guzik, et al.
Pageof 57

Showing results (511-520 of 565) with videos related to

Sort By:
Pageof 57
Health Promotion Practice|November 22, 2023
Implementation of Overdose Prevention in Maryland: Implications for Resource Allocation, Program Scale-Up, and EvaluationCatherine Tomko, Saba Rouhani, Renee M Johnson, et al.
Diabetes|January 9, 2001
Glucagon-like peptide 1 stimulates lipolysis in clonal pancreatic beta-cells (HIT)G C Yaney, V N Civelek, A M Richard, et al.
Leukemia Research|August 17, 2018
CC-486 (oral azacitidine) in patients with myelodysplastic syndromes with pretreatment thrombocytopeniaGuillermo Garcia-Manero, Bart L Scott, Christopher R Cogle, et al.
Journal of Medicinal Chemistry|October 13, 1995
Piperazinylalkyl heterocycles as potential antipsychotic agentsM K Scott, E W Baxter, D J Bennett, et al.
Bioorganic & Medicinal Chemistry|September 6, 2002
Synthesis of (-)-5,8-dihydroxy-3R-methyl-2R-(dipropylamino)-1,2,3,4-tetrahydronaphthalene: an inhibitor of beta-amyloid(1-42) aggregationMichael H Parker, Robert Chen, Kelly A Conway, et al.
Pancreas|March 20, 2013
Improving the success rate of gluteal intramuscular injectionsApril E Boyd, Linda L DeFord, Jeannette E Mares, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 14, 2007
Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemiaSusan O'Brien, Joseph O Moore, Thomas E Boyd, et al.
Journal of Medicinal Chemistry|February 7, 2001
Alpha(2) adrenoceptor agonists as potential analgesic agents. 2. Discovery of 4-(4-imidazo)-1,3-dimethyl-6,7-dihydro-thianaphthene as a high-affinity ligand for the alpha(2D) adrenergic receptorT M Ross, M C Jetter, M E McDonnell, et al.
The Journal of Biological Chemistry|October 9, 2009
Characterization of a serine protease homologous to house dust mite group 3 allergens from the scabies mite Sarcoptes scabieiSimone A Beckham, Sarah E Boyd, Simone Reynolds, et al.
CJC Open|June 21, 2021
Cardiovascular and Renal Risk Factors and Complications Associated With COVID-19Rhian M Touyz, Marcus O E Boyd, Tomasz Guzik, et al.
Pageof 57